Profound Medical Corp(PROF-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low6.52
Day High6.91
Open:6.91
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Profound Medical (PRN) Receives a Buy from Lake Street
Tipranks
Profound Medical Shareholders Back Board, Question Incentive Plan
Tipranks
Profound Medical Highlights TULSA Advances at AUA 2026
GlobeNewswire
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
Newsfile
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
Tipranks
Profound Medical (PRN) Receives a Buy from Lake Street
MarketBeat
Profound Medical Q1 Earnings Call Highlights
MarketBeat.com
GlobeNewswire
Profound Medical Reports Strong First Quarter 2026 Financial Results
Newswire.ca
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
Tipranks
Profound Medical Schedules First-Quarter 2026 Earnings Release
GlobeNewswire
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
Tipranks
Profound Medical to Present Business Update at Conference
GlobeNewswire
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Tipranks
Profound Medical Showcases TULSA-PRO at Key Radiology Meeting
GlobeNewswire
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
Tipranks
Profound Medical Marks Key TULSA Milestone as Texas Prostate Tops 100 Procedures
GlobeNewswire
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
Tipranks
Lake Street Keeps Their Buy Rating on Profound Medical (PRN)
Tipranks
Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes

Profile

Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.